Radcliffe Group Launches New Branding to Signal the Start of a Year of Innovation and Investment
February 10, 2022 10:09 ET
|
Radcliffe Group Ltd
LONDON, England, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Radcliffe Group has unveiled a new brand identity across its core business, including its three specialist channels: Radcliffe Cardiology,...
Global Cardiovascular Needle and Prosthetic Devices Market Trend of 2022 with Insights Research Report, Share By Type, Size By End User, Exploring Sales Volume Revenue, Comprehensive Growth And Forecast 2027
February 10, 2022 08:42 ET
|
360 Market Updates
Pune, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Part 1 : Global Cardiovascular Needle Market The report provides in-depth analysis and insights into the current global market scenario, latest trends,...
CVRx to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 15, 2022
February 01, 2022 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, Feb. 01, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
FDA Pre-Submission Filed for Cardio inCode-SCORE
January 11, 2022 02:30 ET
|
GENinCode Plc
OXFORD, England, Jan. 11, 2022 (GLOBE NEWSWIRE) -- GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the filing of its...
Prolocor to Participate at Biotech Showcase 2022
January 10, 2022 09:00 ET
|
Prolocor Inc
PHILADELPHIA, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Prolocor Inc, a healthcare startup developing an innovative precision diagnostic test that quantifies FcγRIIa on the surface of platelets, today...
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results
January 10, 2022 08:00 ET
|
CVRx, Inc.
MINNEAPOLIS, Jan. 10, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
FDA approves Novartis Leqvio® (inclisiran), first-in-class siRNA to lower cholesterol and keep it low with two doses a year
December 22, 2021 16:05 ET
|
Novartis Pharma AG
Ad hoc announcement pursuant to Art. 53 LR With two maintenance doses a year, Leqvio is the first and only FDA-approved small interfering RNA (siRNA) therapy for LDL-C (bad cholesterol)...
CVRx to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 21, 2021 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, Dec. 21, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
Global Oncology/Cancer Drugs Market to Grow $274.40 Billion by 2030
December 13, 2021 03:33 ET
|
Allied Market Research
Portland, OR, Dec. 13, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Oncology/Cancer Drugs Market was accounted for $135.49 billion in 2020, and is...
Medical Tourism Market Projected to Garner a Revenue of $149.34 Billion by 2026, Growing at a CAGR of 12.4% from 2019-2026 [140-Pages] | Reveals by Research Dive
December 08, 2021 09:00 ET
|
Research Dive
New York, USA, Dec. 08, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global medical tourism market is expected to garner a revenue of $149.34 billion by 2026 and...